Fibrosis

Liver fibrosis is a progressive form of chronic liver injury mediated by persistent NLRP3 inflammasome activation in liver cells called hepatic stellate cells (“HSCs”), which leads to the…

Los Angeles, CA, July 13, 2023 (GLOBE NEWSWIRE) -- Claire’s Place Foundation, a non-profit organization providing support to children and families affected by cystic fibrosis (CF), is…

The mucus in the airways is not as sticky, inflammation in the lungs significantly reduced: Triple combination therapy can achieve these positive, lasting effects in patients with cystic…

Madrigal expects to complete full submission of the New Drug Application in July 2023 CONSHOHOCKEN, Pa., June 30, 2023 (GLOBE NEWSWIRE) -- Madrigal Pharmaceuticals, Inc. (NASDAQ:MDGL), a…

VIENNA – Treatment with an investigational FGF21 analogue improved fibrosis in patients with nonalcoholic…

Company to discontinue all NASH-related investment and restructure the Company’s operations to strengthen its focus on rare and serious liver diseasesCompany anticipates achieving…

BOCA RATON, Fla., June 15, 2023 (GLOBE NEWSWIRE) -- First Wave BioPharma, Inc. (NASDAQ:FWBI) (“First Wave BioPharma” or the “Company”), a clinical-stage biopharmaceutical company…

Intestinal fibrosis is a serious complication of Crohn's disease (CD) without any approved…

<!-- Name:DistributionId Value:8843252 --> <!-- Name:EnableQuoteCarouselOnPnr Value:False -->…

A panel of FDA's outside experts said obeticholic acid (Ocaliva) does not have…